Christopher D. Riemann

Christopher D. Riemann

Auto-generated profile, based on publicly available information

Christopher D. Riemann

University of Cincinnati, Cincinnati, OH, USA

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2001 in Ophthalmology
Verified
Journal Article
Closed access
AMAndrea P Da Mata
Andrea P Da Mata
SBScott E Burk
Scott E Burk
CRChristopher D Riemann
Christopher D Riemann
RRRobert H Rosa
Robert H Rosa
MSMichael E Snyder
Michael E Snyder
RFRobert E Foster
Robert E Foster

1 January 2001 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
PKPeter K Kaiser
Peter K Kaiser
CRChristopher D Riemann
Christopher D Riemann
JSJonathan E Sears
Jonathan E Sears
HLHilel Lewis
Hilel Lewis

1 December 2004 in Ophthalmology
Verified
Journal Article
Closed access
AMAndrea P. Da Mata
Andrea P. Da Mata
SBScott E. Burk
Scott E. Burk
RFRobert E. Foster
Robert E. Foster
CRChristopher D. Riemann
Christopher D. Riemann
MPMichael R. Petersen
Michael R. Petersen
JAJames J. Augsburger
James J. Augsburger

1 January 2016 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
MKM. Ali Khan
M. Ali Khan
ASAbtin Shahlaee
Abtin Shahlaee
BTBrian Toussaint
Brian Toussaint
JHJason Hsu
Jason Hsu
ASArunan Sivalingam
Arunan Sivalingam
AHAllen C Ho
Allen C Ho

1 July 2005 in Journal of Cataract & Refractive Surgery
Verified
Journal Article
Closed access
RLRussell M. LeBoyer
Russell M. LeBoyer
LWLiliana Werner
Liliana Werner
MSMicheal E. Snyder
Micheal E. Snyder
NMNick Mamalis
Nick Mamalis
CRChristopher D. Riemann
Christopher D. Riemann
JAJames J. Augsberger
James J. Augsberger
We report an analysis of 3 single-piece hydrophobic acrylic intraocular lenses (IOLs) that were explanted because of complications related to the presence of their haptics in the ciliary sulcus. In 2 cases, the IOL was primarily implanted in the ciliary sulcus because of inadequate posterior capsule support. In the third case, postoperative displacement of 1 haptic in the sulcus was associated with hyphema and vitreous hemorrhage. Ultrasound biomicroscopy confirmed the contact between the haptic and iris. Areas of iris atrophy were observed in all cases. Light microscopy and scanning electron microscopy of the explanted lenses revealed the presence of pigmentary dispersion on the anterior surfaces. In Case 3, the pigments were concentrated on the surface of the haptic that was displaced from the capsular bag and on the corresponding optic-haptic junction. Scanning electron microscopy also showed the IOL's squared edges and unpolished side walls. The flexibility and thickness of the single-piece hydrophobic acrylic haptics, as well as the square optic and haptic edges, may increase the risk for iris chafing when the haptics are in the sulcus. Therefore, sulcus fixation of this IOL design is not recommended.

1 September 2016 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
ASAma Sadaka
Ama Sadaka
RSRobert Sisk
Robert Sisk
JOJames M Osher
James M Osher
OTOkan Toygar
Okan Toygar
MDMelinda K. Duncan
Melinda K. Duncan
CRChristopher D Riemann
Christopher D Riemann
Purpose: The purpose of this study was to evaluate intravitreal methotrexate infusion (IMI) during pars plana vitrectomy (PPV) for retinal detachment in patients with high risk for the development of proliferative vitreoretinopathy (PVR). Methods: Patients presenting with severe recurrent PVR with tractional retinal detachment and/or a history of severe ocular inflammation were treated with IMI. Clinical outcomes were determined from a retrospective medical chart review. Results: Twenty-nine eyes presenting with either tractional retinal detachment and recurrent PVR (n=22) or a history of severe inflammation associated with high PVR risk (n=7) received IMI during PPV. Best-corrected visual acuity at 6 months was ≥20/200 in 19 of 29 eyes (66%) and remained stable or improved compared with initial presentation in 24 of 29 eyes (83%). At the last follow-up examination, the retinas of 26 of 29 eyes (90%) remained attached after IMI while three eyes required another reattachment procedure. Three additional eyes (10%) developed recurrent limited PVR without recurrent RD and were observed. No complications attributable to IMI occurred during a mean follow-up of 27 months. Conclusion: Eyes at high risk for PVR development due to a history of prior PVR or intraocular inflammation had a low incidence of PVR following IMI at the time of PPV for RD repair. No significant safety issues from IMI were observed in this series.